nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—CYP3A4—Rifampicin—leprosy	0.0973	0.548	CbGbCtD
Etonogestrel—CYP3A4—Dapsone—leprosy	0.0803	0.452	CbGbCtD
Etonogestrel—Embolism venous—Thalidomide—leprosy	0.0257	0.0313	CcSEcCtD
Etonogestrel—Sexual dysfunction—Thalidomide—leprosy	0.0231	0.0281	CcSEcCtD
Etonogestrel—Foetor hepaticus—Thalidomide—leprosy	0.0229	0.0278	CcSEcCtD
Etonogestrel—Enlargement abdomen—Thalidomide—leprosy	0.0216	0.0262	CcSEcCtD
Etonogestrel—Toothache—Thalidomide—leprosy	0.0213	0.0259	CcSEcCtD
Etonogestrel—Galactorrhoea—Thalidomide—leprosy	0.02	0.0243	CcSEcCtD
Etonogestrel—Seborrhoeic dermatitis—Thalidomide—leprosy	0.019	0.0231	CcSEcCtD
Etonogestrel—Liver disorder—Thalidomide—leprosy	0.019	0.0231	CcSEcCtD
Etonogestrel—Metrorrhagia—Thalidomide—leprosy	0.0182	0.0221	CcSEcCtD
Etonogestrel—Acne—Thalidomide—leprosy	0.0154	0.0187	CcSEcCtD
Etonogestrel—Amenorrhoea—Thalidomide—leprosy	0.0148	0.018	CcSEcCtD
Etonogestrel—Herpes simplex—Thalidomide—leprosy	0.0141	0.0171	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Dapsone—leprosy	0.0139	0.0169	CcSEcCtD
Etonogestrel—Bone pain—Thalidomide—leprosy	0.0135	0.0165	CcSEcCtD
Etonogestrel—Sinusitis—Dapsone—leprosy	0.0133	0.0162	CcSEcCtD
Etonogestrel—Hepatocellular injury—Thalidomide—leprosy	0.013	0.0158	CcSEcCtD
Etonogestrel—Pharyngitis—Dapsone—leprosy	0.0126	0.0154	CcSEcCtD
Etonogestrel—Erythema—Dapsone—leprosy	0.0111	0.0135	CcSEcCtD
Etonogestrel—Eczema—Thalidomide—leprosy	0.0105	0.0127	CcSEcCtD
Etonogestrel—Libido decreased—Thalidomide—leprosy	0.0102	0.0123	CcSEcCtD
Etonogestrel—Increased appetite—Thalidomide—leprosy	0.01	0.0122	CcSEcCtD
Etonogestrel—Visual disturbance—Thalidomide—leprosy	0.00994	0.0121	CcSEcCtD
Etonogestrel—Cough—Dapsone—leprosy	0.00967	0.0118	CcSEcCtD
Etonogestrel—Pain in extremity—Thalidomide—leprosy	0.00942	0.0115	CcSEcCtD
Etonogestrel—Disturbance in sexual arousal—Thalidomide—leprosy	0.00934	0.0114	CcSEcCtD
Etonogestrel—Affect lability—Thalidomide—leprosy	0.00927	0.0113	CcSEcCtD
Etonogestrel—Migraine—Thalidomide—leprosy	0.00927	0.0113	CcSEcCtD
Etonogestrel—Mood swings—Thalidomide—leprosy	0.00892	0.0108	CcSEcCtD
Etonogestrel—Breast disorder—Thalidomide—leprosy	0.00851	0.0103	CcSEcCtD
Etonogestrel—Cramp muscle—Thalidomide—leprosy	0.00848	0.0103	CcSEcCtD
Etonogestrel—Abdominal distension—Thalidomide—leprosy	0.00819	0.00996	CcSEcCtD
Etonogestrel—Insomnia—Dapsone—leprosy	0.00818	0.00994	CcSEcCtD
Etonogestrel—Bronchitis—Thalidomide—leprosy	0.00783	0.00952	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Thalidomide—leprosy	0.00757	0.0092	CcSEcCtD
Etonogestrel—Pollakiuria—Thalidomide—leprosy	0.00752	0.00914	CcSEcCtD
Etonogestrel—Weight increased—Thalidomide—leprosy	0.00741	0.00901	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Dapsone—leprosy	0.00739	0.00899	CcSEcCtD
Etonogestrel—Weight decreased—Thalidomide—leprosy	0.00736	0.00895	CcSEcCtD
Etonogestrel—Infestation NOS—Thalidomide—leprosy	0.00726	0.00883	CcSEcCtD
Etonogestrel—Infestation—Thalidomide—leprosy	0.00726	0.00883	CcSEcCtD
Etonogestrel—Depression—Thalidomide—leprosy	0.00724	0.0088	CcSEcCtD
Etonogestrel—Abdominal pain—Dapsone—leprosy	0.00715	0.00869	CcSEcCtD
Etonogestrel—Body temperature increased—Dapsone—leprosy	0.00715	0.00869	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Thalidomide—leprosy	0.00711	0.00865	CcSEcCtD
Etonogestrel—Sinusitis—Thalidomide—leprosy	0.00681	0.00828	CcSEcCtD
Etonogestrel—Rhinitis—Thalidomide—leprosy	0.00653	0.00794	CcSEcCtD
Etonogestrel—Hypoaesthesia—Thalidomide—leprosy	0.00648	0.00788	CcSEcCtD
Etonogestrel—Pharyngitis—Thalidomide—leprosy	0.00647	0.00786	CcSEcCtD
Etonogestrel—Urinary tract disorder—Thalidomide—leprosy	0.00643	0.00782	CcSEcCtD
Etonogestrel—Urethral disorder—Thalidomide—leprosy	0.00639	0.00777	CcSEcCtD
Etonogestrel—Visual impairment—Thalidomide—leprosy	0.00628	0.00763	CcSEcCtD
Etonogestrel—Eye disorder—Thalidomide—leprosy	0.00609	0.0074	CcSEcCtD
Etonogestrel—Angiopathy—Thalidomide—leprosy	0.00591	0.00719	CcSEcCtD
Etonogestrel—Immune system disorder—Thalidomide—leprosy	0.00589	0.00716	CcSEcCtD
Etonogestrel—Alopecia—Thalidomide—leprosy	0.00576	0.007	CcSEcCtD
Etonogestrel—Vomiting—Dapsone—leprosy	0.00575	0.00699	CcSEcCtD
Etonogestrel—Mental disorder—Thalidomide—leprosy	0.00571	0.00694	CcSEcCtD
Etonogestrel—Malnutrition—Thalidomide—leprosy	0.00567	0.0069	CcSEcCtD
Etonogestrel—Headache—Dapsone—leprosy	0.00566	0.00689	CcSEcCtD
Etonogestrel—Flatulence—Thalidomide—leprosy	0.00559	0.0068	CcSEcCtD
Etonogestrel—Tension—Thalidomide—leprosy	0.00557	0.00677	CcSEcCtD
Etonogestrel—Nervousness—Thalidomide—leprosy	0.00551	0.0067	CcSEcCtD
Etonogestrel—Back pain—Thalidomide—leprosy	0.00549	0.00667	CcSEcCtD
Etonogestrel—Muscle spasms—Thalidomide—leprosy	0.00545	0.00663	CcSEcCtD
Etonogestrel—Nausea—Dapsone—leprosy	0.00537	0.00653	CcSEcCtD
Etonogestrel—Ill-defined disorder—Thalidomide—leprosy	0.00526	0.0064	CcSEcCtD
Etonogestrel—Angioedema—Thalidomide—leprosy	0.00518	0.0063	CcSEcCtD
Etonogestrel—Malaise—Thalidomide—leprosy	0.00511	0.00622	CcSEcCtD
Etonogestrel—Cough—Thalidomide—leprosy	0.00495	0.00602	CcSEcCtD
Etonogestrel—Convulsion—Thalidomide—leprosy	0.00491	0.00598	CcSEcCtD
Etonogestrel—Hypertension—Thalidomide—leprosy	0.0049	0.00595	CcSEcCtD
Etonogestrel—Arthralgia—Thalidomide—leprosy	0.00483	0.00587	CcSEcCtD
Etonogestrel—Myalgia—Thalidomide—leprosy	0.00483	0.00587	CcSEcCtD
Etonogestrel—Anxiety—Thalidomide—leprosy	0.00481	0.00585	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.0048	0.00583	CcSEcCtD
Etonogestrel—Discomfort—Thalidomide—leprosy	0.00477	0.0058	CcSEcCtD
Etonogestrel—Oedema—Thalidomide—leprosy	0.00463	0.00563	CcSEcCtD
Etonogestrel—Infection—Thalidomide—leprosy	0.0046	0.00559	CcSEcCtD
Etonogestrel—Nervous system disorder—Thalidomide—leprosy	0.00454	0.00552	CcSEcCtD
Etonogestrel—Skin disorder—Thalidomide—leprosy	0.0045	0.00547	CcSEcCtD
Etonogestrel—Anorexia—Thalidomide—leprosy	0.00441	0.00537	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Thalidomide—leprosy	0.00422	0.00513	CcSEcCtD
Etonogestrel—Insomnia—Thalidomide—leprosy	0.00419	0.00509	CcSEcCtD
Etonogestrel—Paraesthesia—Thalidomide—leprosy	0.00416	0.00505	CcSEcCtD
Etonogestrel—Somnolence—Thalidomide—leprosy	0.00412	0.005	CcSEcCtD
Etonogestrel—Dyspepsia—Thalidomide—leprosy	0.00407	0.00495	CcSEcCtD
Etonogestrel—Decreased appetite—Thalidomide—leprosy	0.00402	0.00489	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Thalidomide—leprosy	0.004	0.00486	CcSEcCtD
Etonogestrel—Fatigue—Thalidomide—leprosy	0.00399	0.00485	CcSEcCtD
Etonogestrel—Constipation—Thalidomide—leprosy	0.00396	0.00481	CcSEcCtD
Etonogestrel—Pain—Thalidomide—leprosy	0.00396	0.00481	CcSEcCtD
Etonogestrel—Feeling abnormal—Thalidomide—leprosy	0.00381	0.00464	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Thalidomide—leprosy	0.00379	0.0046	CcSEcCtD
Etonogestrel—Urticaria—Thalidomide—leprosy	0.00368	0.00447	CcSEcCtD
Etonogestrel—Abdominal pain—Thalidomide—leprosy	0.00366	0.00445	CcSEcCtD
Etonogestrel—Body temperature increased—Thalidomide—leprosy	0.00366	0.00445	CcSEcCtD
Etonogestrel—Hypersensitivity—Thalidomide—leprosy	0.00341	0.00415	CcSEcCtD
Etonogestrel—Asthenia—Thalidomide—leprosy	0.00332	0.00404	CcSEcCtD
Etonogestrel—Pruritus—Thalidomide—leprosy	0.00328	0.00398	CcSEcCtD
Etonogestrel—Diarrhoea—Thalidomide—leprosy	0.00317	0.00385	CcSEcCtD
Etonogestrel—Dizziness—Thalidomide—leprosy	0.00306	0.00372	CcSEcCtD
Etonogestrel—Vomiting—Thalidomide—leprosy	0.00294	0.00358	CcSEcCtD
Etonogestrel—Rash—Thalidomide—leprosy	0.00292	0.00355	CcSEcCtD
Etonogestrel—Dermatitis—Thalidomide—leprosy	0.00292	0.00355	CcSEcCtD
Etonogestrel—Headache—Thalidomide—leprosy	0.0029	0.00353	CcSEcCtD
Etonogestrel—Nausea—Thalidomide—leprosy	0.00275	0.00334	CcSEcCtD
